Cargando…
Bioinformatics roadmap for therapy selection in cancer genomics
Tumour heterogeneity is one of the main characteristics of cancer and can be categorised into inter‐ or intratumour heterogeneity. This heterogeneity has been revealed as one of the key causes of treatment failure and relapse. Precision oncology is an emerging field that seeks to design tailored tre...
Autores principales: | Jiménez‐Santos, María José, García‐Martín, Santiago, Fustero‐Torre, Coral, Di Domenico, Tomás, Gómez‐López, Gonzalo, Al‐Shahrour, Fátima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627786/ https://www.ncbi.nlm.nih.gov/pubmed/35811332 http://dx.doi.org/10.1002/1878-0261.13286 |
Ejemplares similares
-
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
por: Fustero-Torre, Coral, et al.
Publicado: (2021) -
vulcanSpot: a tool to prioritize therapeutic vulnerabilities in cancer
por: Perales-Patón, Javier, et al.
Publicado: (2019) -
PD-L1(ATTAC) mice reveal the potential of depleting PD-L1 expressing cells in cancer therapy
por: Fueyo-Marcos, Elena, et al.
Publicado: (2023) -
In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome
por: Piñeiro-Yáñez, Elena, et al.
Publicado: (2019) -
Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study
por: Moreno-Torres, Irene, et al.
Publicado: (2018)